JW Asset Management’s Cumberland Pharmaceuticals CPIX Stock Holding History

JW Asset Management’s Portfolio CPIX Stock Details CPIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-178,942	Closed	-$1.2M	–	21
2018 Q1	$1.2M	Sell	178,942 -84,939	-32%	-$585K	1.18%	16
2017 Q4	$1.94M	Hold	263,881	–	–	2.07%	13
2017 Q3	$1.86M	Hold	263,881	–	–	1.36%	18
2017 Q2	$1.85M	Hold	263,881	–	–	1.18%	19
2017 Q1	$1.83M	Buy	263,881 +252,942	+2,312%	+$1.53M	0.38%	23
2016 Q4	$61K	Hold	10,939	–	–	0.04%	35
2016 Q3	$55K	Hold	10,939	–	–	0.04%	36
2016 Q2	$49K	Hold	10,939	–	–	0.04%	34
2016 Q1	$49K	Hold	10,939	–	–	0.03%	36
2015 Q4	$58K	Hold	10,939	–	–	0.02%	39
2015 Q3	$63K	Buy	+10,939	New	+$68.2K	0.02%	51

Other funds holding CPIX

Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bard Associates Chicago, Illinois $398M AUM 54.32% 1-Year Est. Return

JW Asset Management's CPIX Position: Q2 2018 in Review

JW Asset Management sold out of Cumberland Pharmaceuticals (CPIX) in Q2 2018, closing a stake of 178,942 shares — an estimated $1.2M sold.

JW Asset Management first reported a position in CPIX in Q3 2015 and held it in 11 quarters. The position peaked at $1.94M in Q4 2017. 30 funds tracked by Wall St. Rank hold CPIX as of Q2 2018.

JW Asset Management reported no remaining Cumberland Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
JW Asset Management sold 178,942 Cumberland Pharmaceuticals shares in Q2 2018, an estimated $1.2M.
JW Asset Management first reported a position in Cumberland Pharmaceuticals in Q3 2015 and held it in 11 quarters.
JW Asset Management's Cumberland Pharmaceuticals position peaked at $1.94M in Q4 2017.
30 funds tracked by Wall St. Rank held Cumberland Pharmaceuticals as of Q2 2018.

Based on JW Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.